Nintedanib is Safe and Effective in Patients with IPF: Results of the INPULSIS Trials

Article Information

DOI 
http://dx.doi.org/10.1177/155989771411008
Published By 
SAGE Publications
Print ISSN 
1559-8977
Online ISSN 
2155-756X
Copyright & Usage 
© 2014 MD Conference Express®

Author Information

  1. Brian Hoyle
  1. Luca Richedli, MD, PhD
    1. University of Southampton, Southampton, United Kingdom
View Full Text

Article usage

AbstractFullPDF
Apr 2015500
May 2015230
Jun 2015600
Jul 2015100
Aug 20152000
Sep 201510500
Oct 2015244
Nov 20155900
Total20074

Note: Article usage statistics are calculated and reported monthly.

Cited By...

  • No citing articles found.
Back to top

Tools

View Full Page PDF
Citation Tools
Email
Nintedanib is Safe and Effective in Patients with IPF: Results of the INPULSIS Trials
Permalink: Copy
Linkedin Share Button del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo StumbleUpon logo

Table of contents

Cited By...

  • No citing articles found.

Keywords

Lower Respiratory Infections
Pulmonary Clinical Trials
Lower Respiratory Infections
Pulmonary Clinical Trials
Pulmonary & Critical Care